US Patent 11260131 Cytotoxic particles for targeting P2X7 receptor
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+200 characters)
Article
Patent abstract
The invention relates to cytotoxic particles for cancer therapy including a core and a plurality of variable domains arranged on the core for binding to P2X7 preceptorson a cancer cell.
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Julian Alexander Barden0
Minoo J Moghaddam0
Xiaojuan Gong0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
112601310
Date of Patent
March 1, 2022
0Patent Application Number
163268820
Date Filed
August 18, 2017
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 5 Apr, 2023
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Mar, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
US Patent 11260131 Cytotoxic particles for targeting P2X7 receptor
Infobox
Is a
Patent jurisdiction
Patent number
11260131
Date of patent
March 1, 2022
Patent application number
16326882
Date Filed
August 18, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 11260131 Cytotoxic particles for targeting P2X7 receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
